Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07806110
What this trial is testing

Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreas Ductal Adenocarcinoma
The First Hospital of Jilin University 62
Testing effectiveness (Phase 2)WithdrawnNCT04481204
What this trial is testing

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03138720
What this trial is testing

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Who this might be right for
Resectable Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma+1 more
HonorHealth Research Institute 40
Testing effectiveness (Phase 2)UnknownNCT02305186
What this trial is testing

Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Craig L Slingluff, Jr 68
Not applicableLooking for participantsNCT05764720
What this trial is testing

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Who this might be right for
Pancreatic Cancer
Varian, a Siemens Healthineers Company 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05562297
What this trial is testing

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIB+1 more
Shanghai Zhongshan Hospital 50
Not applicableUnknownNCT06310902
What this trial is testing

Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients

Who this might be right for
Pancreatic Neoplasms
Fujian Medical University Union Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02749136
What this trial is testing

Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Asan Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT02676349
What this trial is testing

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Who this might be right for
Pancreatic Carcinoma
Institut de Cancérologie de Lorraine 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940286
What this trial is testing

Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaStage IA Pancreatic Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)UnknownNCT03777462
What this trial is testing

Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1

Who this might be right for
Pancreatic Cancer
Changhai Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01726582
What this trial is testing

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Who this might be right for
Pancreatic Adenocarcinoma
Medical College of Wisconsin 229
Testing effectiveness (Phase 2)Looking for participantsNCT06435260
What this trial is testing

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hebei Medical University Fourth Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748611
What this trial is testing

SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
Northwestern University 125
Testing effectiveness (Phase 2)Ended earlyNCT02405585
What this trial is testing

Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Carcinoma Non-resectable
NewLink Genetics Corporation 10
Early research (Phase 1)Looking for participantsNCT07645651
What this trial is testing

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
University of Washington 15
Testing effectiveness (Phase 2)Study completedNCT02243358
What this trial is testing

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreas Neoplasm Malignant Resectable
Henry Ford Health System 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698613
What this trial is testing

EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical ResectionPancreatic Cancer BorderlinePancreatic Cancer Resectable
Brown University 30
Testing effectiveness (Phase 2)UnknownNCT01333332
What this trial is testing

Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
University of Virginia 35
Large-scale testing (Phase 3)Looking for participantsNCT06714604
What this trial is testing

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas Cancer+3 more
Sahlgrenska University Hospital 432
Next Page